Impax Asset Management Group PLC Bristol Myers Squibb CO Transaction History
Impax Asset Management Group PLC
- $15.6 Billion
- Q2 2025
A detailed history of Impax Asset Management Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Impax Asset Management Group PLC holds 152,295 shares of BMY stock, worth $6.78 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
152,295
Previous 131,431
15.87%
Holding current value
$6.78 Million
Previous $8.02 Million
12.05%
% of portfolio
0.05%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...